Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Outcome of special types of luminal breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Breast cancer subtypes and outcome after local and regional relapseE Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Breast Cancer Research and Treatment|April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello, P Maisonneuve, N Rotmensz, et al.
Scientific Reports|February 10, 2025
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgeryL I Sgaramella, A Pasculli, M Moschetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2011
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trialG Viale, M M Regan, P Dell'Orto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancerG Viale, A Giobbie-Hurder, B A Gusterson, et al.
Pageof 2